Τίτλος:
Electroretinographic and optical coherence tomography findings in breast cancer patients using aromatase inhibitors
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Background: The present cross-sectional study has the purpose to investigate the impact of aromatase inhibitors (AIs) on retinal nerve fiber layer (RNFL) thickness, optic nerve and macular function in patients using AIs for breast cancer treatment. Methods: Participants in our study were 41 hormone-receptor-positive earlystage breast cancer patients who were treated with AIs in the adjuvant setting. Moreover, 40 age- and gender-matched control subjects, having neither ocular nor systemic disorders, were included in this study. All participants underwent a complete ophthalmological examination, including best corrected visual acuity (BCVA) assessment, RNFL thickness and central foveal thickness (CFT) measurement, visual evoked potentials (VEP) recording and multifocal-electroretinogram (mf-ERG) recording. Univariate and multiple regression analyses were performed. Results: At the multiple regression analyses, patients receiving AIs presented with lower average RNFL and inferior RNFL. Moreover, similarly to the univariate analysis, intake of AIs was associated with lower amplitude P100, lower retinal response density in ring 1 and ring 2, longer peak time P100 and longer P1 time in ring 1. Conclusion: Our study is the first in the literature investigating the potential effect of AIs on RNFL thickness, optic nerve and macular function in patients using AIs for breast cancer treatment. The principal message of our study is that patients using AIs exhibited a significant decrease in RNFL thickness (average, superior and inferior), retinal response density and visual acuity compared to healthy controls, while VEP findings (both amplitude and peak time of P100) differ significantly as well. © 2015 Informa Healthcare USA, Inc.
Συγγραφείς:
Moschos, M.M.
Chatziralli, I.P.
Sergentanis, T.
Zagouri, F.
Chrysikos, D.
Ladas, I.
Zografos, G.
Περιοδικό:
Cutaneous and Ocular Toxicology (formerly Journal of Toxicology - Cutaneous and Ocular Toxicology)
Εκδότης:
Taylor and Francis Ltd.
Λέξεις-κλειδιά:
anastrozole; aromatase inhibitor; exemestane; letrozole; anastrozole; androstane derivative; aromatase inhibitor; exemestane; letrozole; nitrile; triazole derivative, adjuvant therapy; adult; Article; breast cancer; cancer hormone therapy; cancer patient; central retinal thickness; controlled study; cross-sectional study; drug effect; early cancer; electroretinography; evoked visual response; eye examination; eye toxicity; human; major clinical study; optic nerve; optical coherence tomography; optical coherence tomography device; retinal nerve fiber layer thickness; treatment duration; visual acuity; visual system function; Breast Neoplasms; controlled clinical trial; drug effects; electroretinography; female; middle aged; nerve fiber; optical coherence tomography; pathology; retina; visual evoked potential, Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Electroretinography; Evoked Potentials, Visual; Female; Humans; Middle Aged; Nerve Fibers; Nitriles; Optic Nerve; Retina; Tomography, Optical Coherence; Triazoles; Visual Acuity
DOI:
10.3109/15569527.2014.1003267
